sod2 Antibody

What is SOD2 and why is it important in cellular biology?

SOD2 (superoxide dismutase 2, mitochondrial), also known as IPOB, MNSOD, SODM, or Mn-SOD, belongs to the iron/manganese superoxide dismutase family and serves as a primary defense mechanism against oxidative stress within cells. This vital mitochondrial enzyme catalyzes the dismutation of superoxide anion into hydrogen peroxide and oxygen, protecting cells from reactive oxygen species (ROS) generated during cellular respiration .

SOD2 is synthesized in the cytosol as a precursor protein and undergoes critical post-translational modifications, including mitochondrial targeting and cleavage of its N-terminal signal sequence, enabling proper localization within the mitochondrial matrix . The fully processed protein has an observed molecular weight of approximately 25 kDa . Dysregulation or mutation in SOD2 is linked to numerous diseases, including neurodegenerative conditions like Alzheimer's and Parkinson's disease, as well as cardiovascular conditions such as ischemic heart disease and idiopathic dilated cardiomyopathy .

How should I select the appropriate SOD2 antibody for my experimental needs?

When selecting an SOD2 antibody, consider these critical factors:

• Host Species and Antibody Type:

  • Available options include rabbit polyclonal (e.g., AF4660, CSB-PA022398LA01HU) and mouse monoclonal antibodies (e.g., B-1)

  • Polyclonal antibodies recognize multiple epitopes, potentially increasing sensitivity

  • Monoclonal antibodies offer higher specificity for a single epitope

• Target Species Reactivity:

  • Confirm reactivity with your study species (human, mouse, rat)

  • Some antibodies have predicted reactivity to additional species (pig, zebrafish, bovine, horse, sheep, rabbit, xenopus)

• Application Compatibility:

  • Verify validation for your specific application (WB, IHC, IF/ICC, FC, ELISA, IP)

  • Review recommended dilutions for your application method

• Conjugation Requirements:

  • Choose between unconjugated or conjugated forms:

    • HRP conjugated for enhanced detection sensitivity

    • FITC or other fluorescent conjugates for direct visualization

    • Biotin conjugated for amplification systems

• Validation Data:

  • Review published validation data in cell lines and tissues similar to your experimental system

  • Check molecular weight confirmation (approximately 25 kDa)

What are the optimal storage conditions for maintaining SOD2 antibody activity?

For maximum antibody stability and performance:

Store SOD2 antibodies at -20°C, where they typically remain stable for one year after shipment . Most SOD2 antibodies are supplied in a storage buffer containing PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 . For some products, aliquoting is unnecessary for -20°C storage, which simplifies handling procedures . Some preparations (particularly smaller 20μl sizes) may contain 0.1% BSA as a stabilizer .

When working with the antibody, avoid repeated freeze-thaw cycles by preparing single-use aliquots. Before each use, centrifuge the vial briefly to collect all material at the bottom. For dilutions, use buffers recommended in the product datasheet, typically containing a carrier protein such as BSA.

What are the recommended dilutions and applications for SOD2 antibodies?

SOD2 antibodies have been validated across multiple applications with specific optimal dilution ranges:

For optimal results, it is recommended to titrate the antibody in each specific experimental system . Some applications may require specific buffer conditions - for example, IHC applications suggest antigen retrieval with TE buffer at pH 9.0 or alternatively with citrate buffer at pH 6.0 .

What controls should be included when using SOD2 antibodies in experimental designs?

A rigorous experimental design with SOD2 antibodies should include these controls:

• Positive Controls:

  • Include validated cell lines or tissues known to express SOD2:

    • HepG2, HeLa, HEK-293, SH-SY5Y, NIH/3T3 cells

    • Mouse or rat brain tissue

    • HUVEC cells (for IF)

  • Consider including samples with upregulated SOD2 (e.g., cells under oxidative stress)

• Negative Controls:

  • Primary antibody omission control to detect non-specific binding of secondary antibody

  • Isotype control (irrelevant antibody of same isotype, e.g., Rabbit/IgG or Mouse IgG2b κ)

  • SOD2-knockdown or knockout samples (when available)

• Loading/Technical Controls:

  • For Western blot: Include appropriate loading controls like GAPDH

  • For IHC/IF: Include parallel sections stained with standard markers

  • For flow cytometry: Include unstained and single-stained controls for compensation

• Application-Specific Controls:

  • For IP: Include "beads only" control without antibody

  • For multiplex applications: Include single-stained samples to control for bleed-through

These controls help validate antibody specificity, establish appropriate experimental conditions, and support accurate interpretation of results.

What antigen retrieval methods are optimal for SOD2 immunohistochemistry?

For optimal SOD2 detection in fixed tissue sections:

The recommended primary antigen retrieval method for SOD2 IHC is TE buffer at pH 9.0, with an alternative option being citrate buffer at pH 6.0 . This recommendation is based on validation data from human ovary cancer tissue samples .

For challenging samples or to troubleshoot weak staining:

• Consider heat-induced epitope retrieval (HIER) methods:

  • Pressure cooker: 3-5 minutes at full pressure

  • Microwave: 10-20 minutes on medium power

  • Water bath: 20-40 minutes at 95-98°C

• Optimize incubation parameters:

  • Extend primary antibody incubation (overnight at 4°C)

  • Increase antibody concentration within recommended ranges (1:1500-1:6000)

• Enhance signal detection:

  • Use polymer-based detection systems for higher sensitivity

  • Consider amplification steps for low-abundance targets

  • Optimize chromogen development time

The optimal retrieval method may vary depending on tissue type, fixation method, and processing conditions. Systematic comparison of different methods is recommended when establishing a new IHC protocol.

How can SOD2 antibodies be used to study mitochondrial oxidative stress mechanisms?

SOD2 antibodies provide powerful tools for investigating mitochondrial oxidative stress mechanisms:

• Expression Analysis During Oxidative Stress:

  • Use Western blot to quantify SOD2 protein levels in response to:

    • Pharmacological inducers of oxidative stress

    • Pathological conditions associated with ROS generation

    • Genetic modifications affecting mitochondrial function

  • Recommended dilutions of 1:5000-1:50000 for sensitive detection

• Subcellular Localization Studies:

  • Employ immunofluorescence (IF) to visualize SOD2 distribution:

    • Combined with mitochondrial markers to confirm localization

    • Track changes in distribution during stress responses

    • Examine perinuclear restriction patterns characteristic of mitochondrial localization

  • Use recommended IF dilutions of 1:400-1:1600

• Cell-Type Specific Analysis:

  • Apply flow cytometry to quantify SOD2 levels in specific cell populations:

    • Differentiate responses in heterogeneous tissues

    • Sort cells based on SOD2 expression levels

    • Combine with viability markers to correlate with cell survival

  • Use recommended concentration of 0.25 μg per 10^6 cells

• Tissue Damage Assessment:

  • Utilize IHC to examine SOD2 expression patterns in:

    • Ischemic tissues

    • Inflammatory conditions

    • Degenerative disorders

  • Compare with markers of oxidative damage to establish correlations

• Interaction Studies:

  • Implement immunoprecipitation to identify:

    • Protein-protein interactions influenced by oxidative stress

    • Post-translational modifications occurring during stress responses

    • Complexes involving SOD2 in mitochondrial protection mechanisms

These methodologies provide complementary approaches to understanding the dynamic role of SOD2 in countering mitochondrial oxidative stress.

What approaches can be used to study SOD2 post-translational modifications with antibodies?

Studying SOD2 post-translational modifications (PTMs) requires strategic antibody-based approaches:

• PTM-Specific Antibody Strategies:

  • Use specialized antibodies targeting modified SOD2 forms:

    • Phospho-specific antibodies

    • Acetylation-specific antibodies

    • Ubiquitination-specific antibodies

  • Combine with total SOD2 antibodies to determine modification ratio

• Sequential Immunoprecipitation Approach:

  • First IP: Capture total SOD2 using validated antibodies

    • Use recommended IP dilution range (1:200-1:2000)

  • Second step: Probe with PTM-specific antibodies

    • Alternatively, perform IP with PTM antibodies and detect with SOD2 antibodies

• Differential Detection Methods:

  • Use 2D gel electrophoresis to separate SOD2 isoforms:

    • First dimension: Isoelectric focusing separates by charge (affected by PTMs)

    • Second dimension: SDS-PAGE separates by molecular weight

    • Western blot with SOD2 antibodies to detect specific isoforms

• Enrichment Protocols:

  • Use phosphatase inhibitors to preserve phosphorylation

  • Apply deacetylase inhibitors to maintain acetylation states

  • Include proteasome inhibitors to prevent degradation of ubiquitinated forms

• Comparative Analysis:

  • Examine PTM changes under different conditions:

    • Normal vs. stress conditions

    • Disease vs. healthy states

    • Different developmental stages

These approaches allow researchers to understand how PTMs regulate SOD2 function, which is critical since modifications can significantly alter its enzymatic activity and protective capacity against oxidative stress.

How can SOD2 antibodies be used to investigate mitochondrial dynamics and mitophagy?

SOD2 antibodies can serve as valuable tools for studying mitochondrial quality control processes:

• Mitochondrial Dynamics Visualization:

  • Combine SOD2 immunofluorescence with markers of mitochondrial morphology:

    • Track changes in SOD2 distribution during fusion/fission events

    • Correlate SOD2 levels with mitochondrial network status

  • Use recommended IF dilutions (1:400-1:1600) for optimal resolution

• Mitophagy Monitoring:

  • Dual immunostaining approach:

    • SOD2 as a mitochondrial content marker

    • Autophagy proteins (LC3, p62) to identify autophagosomes

    • Lysosomes (LAMP1, LAMP2) to visualize degradative compartments

  • Quantify SOD2 degradation as an indicator of mitochondrial clearance

• Live-Cell Compatible Strategies:

  • Flow cytometry for population analysis:

    • Measure SOD2 levels in permeabilized cells

    • Combine with mitochondrial membrane potential dyes

    • Correlate with cell viability markers

  • Use validated protocols for intracellular staining (0.25 μg per 10^6 cells)

• Biochemical Fractionation:

  • Western blot analysis of different cellular compartments:

    • Cytosolic vs. mitochondrial fractions

    • Autophagic vesicle fractions

    • Lysosomal fractions

  • Track SOD2 redistribution during mitophagy using recommended dilutions (1:5000-1:50000)

• Quantitative Time-Course Studies:

  • Sequential sampling to monitor:

    • SOD2 levels during mitophagy induction

    • Correlation with mitochondrial mass markers

    • Relationship to oxidative stress markers

These methodologies provide complementary approaches to understanding how mitochondrial dynamics and quality control mechanisms involve or affect SOD2-containing mitochondria in normal physiology and disease states.

How can SOD2 antibodies contribute to neurodegenerative disease research?

SOD2 antibodies provide critical tools for investigating the role of mitochondrial oxidative stress in neurodegenerative conditions:

• Expression Pattern Analysis:

  • Apply immunohistochemistry (IHC) to examine:

    • SOD2 distribution in different brain regions

    • Changes in expression patterns in disease models

    • Correlation with pathological hallmarks

  • Use recommended IHC dilutions (1:1500-1:6000) for optimal staining

• Cellular Model Investigations:

  • Employ Western blot to quantify SOD2 in neuronal models:

    • Track expression changes during disease progression

    • Compare responses to neurotoxic stimuli

    • Evaluate effects of neuroprotective interventions

  • SOD2 antibodies have been validated in neuronal cell lines such as SH-SY5Y

• Co-localization Studies:

  • Implement double immunofluorescence to examine:

    • Relationship between SOD2 and disease-specific protein aggregates

    • Association with markers of oxidative damage

    • Interaction with mitochondrial dysfunction indicators

  • Use recommended IF dilutions (1:400-1:1600) for clear visualization

• Animal Model Validation:

  • SOD2 antibodies have been validated in mouse and rat brain tissue , enabling:

    • Longitudinal studies in disease models

    • Comparative analyses between genetic variants

    • Evaluation of therapeutic interventions

• Human Tissue Analysis:

  • Apply SOD2 antibodies to post-mortem human brain samples:

    • Compare SOD2 levels between patients and controls

    • Correlate with disease severity and duration

    • Examine relationship with genetic risk factors

These approaches help elucidate the mechanistic links between mitochondrial oxidative stress and neurodegenerative pathology, potentially identifying new therapeutic targets.

What methodological approaches can be used to study SOD2 in cancer research?

SOD2 antibodies enable multiple approaches to investigate the complex role of mitochondrial redox regulation in cancer:

• Tumor Expression Profiling:

  • Implement IHC on tissue microarrays:

    • Compare SOD2 levels across tumor types and grades

    • Correlate with patient outcomes and treatment responses

    • Identify cancer-specific expression patterns

  • SOD2 antibodies have been validated in human ovary cancer tissue

• Cell Line Model Studies:

  • Apply Western blot to examine:

    • Baseline SOD2 expression in different cancer cell lines

    • Changes in response to therapeutic agents

    • Effects of genetic manipulations

  • SOD2 antibodies have been validated in multiple cancer cell lines including HepG2, HeLa, and others

• Intracellular Analysis:

  • Utilize flow cytometry to:

    • Quantify SOD2 levels at single-cell resolution

    • Identify heterogeneous populations within tumors

    • Correlate with other cancer markers

  • Follow validated protocols using 0.25 μg antibody per 10^6 cells

• Functional Correlation Studies:

  • Combine SOD2 detection with:

    • ROS measurement assays

    • Cell survival/apoptosis markers

    • Mitochondrial function parameters

• Therapy Response Monitoring:

  • Track SOD2 expression changes:

    • Before and after treatment

    • In resistant vs. sensitive tumors

    • In combination therapy approaches

These methodological approaches help unravel the dual role of SOD2 in cancer - potentially tumor-suppressive through ROS detoxification but also potentially tumor-promoting by enabling adaptation to oxidative stress.

How can SOD2 antibodies be applied in cardiovascular disease research?

For cardiovascular research, SOD2 antibodies provide valuable tools to investigate oxidative stress mechanisms:

• Tissue Expression Analysis:

  • Apply IHC to examine SOD2 in:

    • Normal vs. diseased cardiac tissue

    • Different cardiac cell types (cardiomyocytes, fibroblasts, endothelial cells)

    • Various regions of the heart and vasculature

  • Use recommended dilutions (1:1500-1:6000) for precise localization

• Vascular Endothelium Studies:

  • Implement immunofluorescence to visualize:

    • SOD2 distribution in endothelial cells

    • Changes during endothelial dysfunction

    • Response to hemodynamic stress

  • SOD2 antibodies have been validated in HUVEC cells

• Ischemia-Reperfusion Models:

  • Employ Western blot to quantify:

    • SOD2 expression changes during ischemia/reperfusion

    • Protective responses to preconditioning

    • Effects of cardioprotective interventions

  • Use recommended dilutions (1:5000-1:50000) for sensitive detection

• Flow Analysis of Cardiac Cell Populations:

  • Apply flow cytometry to:

    • Isolate and analyze specific cardiac cell types

    • Correlate SOD2 levels with cell viability

    • Track changes during disease progression

• Clinical Sample Correlation:

  • Analyze SOD2 in patient samples:

    • Comparing expression in different cardiovascular conditions

    • Correlating with clinical parameters

    • Assessing relationship with biomarkers of oxidative stress

These approaches help elucidate how mitochondrial antioxidant defense mechanisms contribute to cardiovascular homeostasis and pathology, potentially identifying new therapeutic strategies for heart disease and vascular disorders.

What strategies can resolve common issues when using SOD2 antibodies in Western blotting?

When encountering challenges with SOD2 detection by Western blot, consider these troubleshooting approaches:

• No Signal or Weak Signal:

  • Optimize antibody concentration - SOD2 antibodies have a wide recommended dilution range (1:500-1:50000)

  • Increase protein loading - SOD2 has moderate expression in many tissues

  • Extend primary antibody incubation (overnight at 4°C)

  • Use enhanced chemiluminescence (ECL) detection systems

  • Verify sample preparation preserves mitochondrial proteins

• Multiple Bands or Unexpected Molecular Weight:

  • Confirm expected molecular weight (approximately 25 kDa)

  • Use fresh samples to prevent degradation

  • Include protease inhibitors during sample preparation

  • Optimize gel percentage for proteins in the 25 kDa range

  • Consider detection of post-translationally modified forms

• High Background:

  • Increase blocking time or blocker concentration

  • Use more stringent washing conditions

  • Dilute primary antibody further within recommended range

  • Test alternative blocking agents (BSA vs. milk)

  • Ensure secondary antibody compatibility and specificity

• Inconsistent Results:

  • Standardize protein extraction protocols

  • Use validated positive controls (HepG2, HeLa, HEK-293 cells)

  • Normalize to appropriate loading controls

  • Consider using a different SOD2 antibody clone

  • Validate with knockout/knockdown controls

• Specific Sample Type Challenges:

  • For tissue samples: Optimize homogenization and extraction buffers

  • For cell lines: Ensure adequate mitochondrial extraction

  • For mitochondrial fractions: Verify enrichment with mitochondrial markers

These methodical troubleshooting approaches can help resolve technical issues and ensure reliable SOD2 detection by Western blot.

How can nonspecific binding be minimized in immunohistochemistry with SOD2 antibodies?

To achieve optimal specificity in SOD2 immunohistochemistry:

• Optimize Blocking Conditions:

  • Extend blocking step duration (1-2 hours)

  • Test different blocking agents:

    • Normal serum matching secondary antibody species

    • Commercial protein-based blockers

    • Mixture of BSA and non-ionic detergents

  • Consider specialized blocking for tissues with high endogenous biotin

• Refine Antibody Parameters:

  • Titrate antibody concentration within recommended range (1:1500-1:6000)

  • Extend antibody incubation time with lower concentrations

  • Conduct incubation at 4°C overnight to improve specificity

  • Use antibody diluents containing carriers and stabilizers

• Enhance Washing Procedures:

  • Increase number of wash steps (5-6 exchanges)

  • Extend wash duration (10-15 minutes per wash)

  • Include mild detergents in wash buffers (0.05-0.1% Tween-20)

  • Use gentle agitation during washing

• Optimize Antigen Retrieval:

  • Follow recommended retrieval conditions (TE buffer pH 9.0 or citrate buffer pH 6.0)

  • Adjust retrieval time based on tissue type and fixation

  • Allow slides to cool slowly after heat-induced retrieval

  • Filter retrieval solutions to remove particulates

• Implement Technical Controls:

  • Include no-primary antibody controls

  • Use isotype-matched control antibodies

  • Test antibody specificity on known positive and negative tissues

  • Consider adsorption controls with immunizing peptide

These approaches help minimize nonspecific binding while maintaining sensitive detection of genuine SOD2 expression in tissue sections.

What are best practices for validating SOD2 antibody specificity in new experimental systems?

When adapting SOD2 antibodies to new experimental systems, thorough validation ensures reliable results:

• Multi-application Cross-validation:

  • Confirm SOD2 detection using complementary techniques:

    • Western blot to verify molecular weight (25 kDa)

    • Immunofluorescence to confirm subcellular localization

    • Flow cytometry to quantify expression levels

  • Consistent results across methods strengthen confidence in antibody specificity

• Genetic Validation Approaches:

  • Compare staining in:

    • SOD2 knockdown/knockout systems

    • SOD2 overexpression systems

    • Dose-dependent expression systems

  • Antibody signal should correlate with genetic manipulation

• Species and Sample Type Validation:

  • Test antibody on known positive controls from relevant species:

    • Human: HepG2, HeLa, HEK-293 cells

    • Mouse: Brain tissue, NIH/3T3 cells

    • Rat: Brain tissue

  • Verify reactivity across relevant tissue types

• Epitope Analysis:

  • Review antibody epitope information:

    • Full-length SOD2 protein (amino acids 1-222)

    • SOD2 fusion protein (Ag21388)

  • Consider potential conservation across species

  • Evaluate potential for cross-reactivity with related proteins

• Literature Comparison:

  • Compare results with published SOD2 expression patterns

  • Assess consistency with known biological contexts

  • Consider known regulation under experimental conditions

These validation strategies ensure that SOD2 antibodies perform reliably in new experimental systems, providing confidence in research findings and facilitating accurate interpretation of results.